News
Novartis is proud to share that CEO Vas Narasimhan, M.D., has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health.
FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...
European countries must match ambition with action — and reward the kind of pharmaceutical innovation they say they want to lead.
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Our mission is to support high quality educational programs for US HCPs that will improve patient care. We will evaluate professional medical education grant requests that are independent of ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
Explore opportunities with Novartis below.
Job Title Sort ascending Business Location Site Date Posted ES PMO & Engagement Lead Regular, Full time CTS India Hyderabad (Office) Apr 21, 2025 Channel Operation Specialist Regular, Full time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results